These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2381458)

  • 1. Serum deoxythymidine kinase as a progressive marker of hematological malignancy.
    Doi S; Naito K; Yamada K
    Nagoya J Med Sci; 1990 Mar; 52(1-4):19-26. PubMed ID: 2381458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum deoxythymidine kinase in hematological malignancy].
    Naito K; Yamada K
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3221-6. PubMed ID: 3196040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in-house assay for serum deoxythymidine kinase.
    Seah LH; Ton SH; Cheong SK; Hamidah NH
    Malays J Pathol; 1991 Dec; 13(2):109-13. PubMed ID: 1823092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum deoxythymidine kinase activity in adult T-cell leukemia].
    Kagimoto T; Oda T; Nakakuma H; Kawaguchi T; Hidaka M; Horikawa K; Matsuzaki H; Takatsuki K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):63-7. PubMed ID: 1987901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.
    Gronowitz JS; Hagberg H; Källander CF; Simonsson B
    Br J Cancer; 1983 Apr; 47(4):487-95. PubMed ID: 6849793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum thymidine kinase in hematologic malignancies.
    Luoni R; Ucci G; Riccardi A; Spriano P; Danova M; Cassano E; Molinari E; Ascari E
    Haematologica; 1988; 73(1):31-5. PubMed ID: 3131202
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes of serum thymidine kinase in children with acute leukemia.
    Votava T; Topolcan O; Holubec L; Cerna Z; Sasek L; Finek J; Kormunda S
    Anticancer Res; 2007; 27(4A):1925-8. PubMed ID: 17649797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thymidine kinase: a serum marker in clinical medicine].
    Llobell Segui GJ; Blasco Ferrandiz RF; Barbero Marín A; Gómez de Terreros FJ; Callol Sánchez L
    An Med Interna; 1989 Jul; 6(7):381-5. PubMed ID: 2562370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary pseudouridine in patients with lymphoma: comparison with other clinical parameters.
    Masaki Y; Itoh K; Sawaki T; Karasawa H; Kawanami T; Fukushima T; Kawabata H; Wano Y; Hirose Y; Suzuki T; Sugai S; Umehara H
    Clin Chim Acta; 2006 Sep; 371(1-2):148-51. PubMed ID: 16643879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia.
    Fujiwara H; Arima N; Ohtsubo H; Matsumoto T; Kukita T; Kawada H; Imaizumi R; Ozaki A; Matsushita K; Tei C
    Am J Hematol; 2002 Oct; 71(2):80-4. PubMed ID: 12353304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs.
    von Euler HP; Ohrvik AB; Eriksson SK
    Res Vet Sci; 2006 Feb; 80(1):17-24. PubMed ID: 16140350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of activities of thymidine metabolizing enzymes in human leukemia-lymphoma cells.
    Shiotani T; Hashimoto Y; Tanaka T; Irino S
    Cancer Res; 1989 Mar; 49(5):1090-4. PubMed ID: 2917346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum thymidine kinase in the monitoring of lymphoma patients].
    Rauhala A; Rantalaiho V; Almqvist A; Putkonen M
    Duodecim; 1995; 111(5):428-34. PubMed ID: 8674444
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of thymidine kinase in the cerebrospinal fluid as a marker of leukemic meningosis].
    Musto P; Cascavilla N; Ladogana S; Modoni S; Carotenuto M
    Medicina (Firenze); 1989; 9(1):49-51. PubMed ID: 2739531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance.
    Wada M; Kosaka M; Saito S; Sano T; Tanaka K; Ichihara A
    J Lab Clin Med; 1993 Feb; 121(2):215-23. PubMed ID: 8433038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic importance of thymidine kinase in colorectal and breast cancer.
    Svobodova S; Topolcan O; Holubec L; Treska V; Sutnar A; Rupert K; Kormunda S; Rousarova M; Finek J
    Anticancer Res; 2007; 27(4A):1907-9. PubMed ID: 17649793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between tumor proliferation and serum levels of beta 2-microglobulin and thymidine kinase in malignant lymphomas.
    Lehtinen T
    Cancer Detect Prev; 1988; 12(1-6):125-31. PubMed ID: 3052829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidine kinase in neoplastic haematological diseases: confirmations, doubts and new findings.
    Musto P; Longo S; Morelli A; Ficola U; Falcone A; Carotenuto M
    Haematologica; 1988; 73(6):545-6. PubMed ID: 3148519
    [No Abstract]   [Full Text] [Related]  

  • 19. Thymidine kinase levels correlate with prognosis in aggressive lymphoma and can discriminate patients with a clinical suspicion of indolent to aggressive transformation.
    Gatt ME; Goldschmidt N; Kalichman I; Friedman M; Arronson AC; Barak V
    Anticancer Res; 2015 May; 35(5):3019-26. PubMed ID: 25964590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.